Literature DB >> 12482131

Microangiopathic hemolysis refractory to plasmapheresis responding to docetaxel and cisplatin: a case report.

George Marcoullis1, Lool Abebe, Dharamvir Jain, Richard Talusan, Niyati Bhagwati, Peter H Wiernik.   

Abstract

We report the case of a 56-yr-old woman with adenocarcinoma of unknown origin metastatic to the bone marrow presenting with a thrombotic thrombocytopenic purpura-like syndrome refractory to protracted daily plasmapheresis and steroids but readily and completely responsive to docetaxel plus cisplatin. Sustained and complete response was pathologically confirmed.

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12482131     DOI： 10.1385/MO:19:3:189

Source DB:  PubMed          Journal:  Med Oncol        ISSN： 1357-0560            Impact factor:   3.064


  6 in total

1.  Microangiopathic haemolytic anaemia in metastasizing malignant tumours is not associated with a severe deficiency of the von Willebrand factor-cleaving protease.

Authors:  S Fontana; H E Gerritsen; J Kremer Hovinga; M Furlan; B Lämmle
Journal:  Br J Haematol       Date:  2001-04       Impact factor: 6.998

2.  Thrombotic thrombocytopenic purpura in metastatic carcinoma of the breast.

Authors:  N von Bubnoff; M Sandherr; F Schneller; C Peschel
Journal:  Am J Clin Oncol       Date:  2000-02       Impact factor: 2.339

3.  Treatment of thrombotic thrombocytopenic purpura with vincristine.

Authors:  L A Gutterman; T D Stevenson
Journal:  JAMA       Date:  1982-03-12       Impact factor: 56.272

Review 4.  [Thrombotic thrombocytopenic purpura disclosing cancer: apropos of 2 cases].

Authors:  P Girard; B Tardy; Y Page; J F Mosnier; B Tardy-Poncet; J C Bertrand
Journal:  Presse Med       Date:  1995-01-21       Impact factor: 1.228

5.  Cisplatin-based combination chemotherapy in the treatment of poorly differentiated carcinoma and poorly differentiated adenocarcinoma of unknown primary site: results of a 12-year experience.

Authors:  J D Hainsworth; D H Johnson; F A Greco
Journal:  J Clin Oncol       Date:  1992-06       Impact factor: 44.544

6.  Thrombotic thrombocytopenic purpura associated with metastatic gastric adenocarcinoma: successful management with plasmapheresis.

Authors:  D J Carr; B S Kramer; D E Dragonetti
Journal:  South Med J       Date:  1986-04       Impact factor: 0.954
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.